Study with ‘powerful results’ finds that combining two existing therapies could extend the life of men with advanced, high-risk prostate cancer by 37%
- Jessica Glenza in Chicago, Illinois
- The Guardian
Combining two existing prostate cancer therapies could extend the life of men with advanced, high-risk prostate cancer by 37%, according to a study presented at the world’s largest…
The new findings could change how doctors first approach treatment of prostate…